Search

In a week's time we'll be heading to Madrid for the Annual European Congress of Rheumatology 2019 (EULAR) for a busy few days of exhibiting, networking and sharing of the latest knowledge. 


There's a packed programme of science to explore and we're really pleased to see our patient registry work showcased in a number of sessions, including the opening plenary:

ORALS:
What to choose: a second TNFi or an alternative class of biologic for patients with JIA who have failed their first TNFi
L. Kearsley-Fleet, R. Davies, J. Page, E. Baildam, M. Beresford, H. Foster, T. Southwood, W. Thomson, K. Hyrich. 
Wednesday 12 June, Opening Plenary Abstract Session 16.15-17.45 in Hall 6, 16.15 Abstract Number OP0016


Factors associated with acute anterior uveitis in patients with axial Spondyloarthritis: analysis of the BSRBR-AS register database
M.H. Derakhshan, L.E. Dean, G.T. Jones, G.J. Macfarlane, S. Siebert, K. Gaffney. 
Friday 14 June, Epidemiology session 10.15-11.45 in room N101/N102, 10.30 Abstract Number OP0262


The impact of extra-articular manifestations on the choice of TNF inhibitor in patients with axial Spondyloarthritis in the BSRBR-AS register
M.H. Derkhshan, L.E. Dean, G.T. Jones, G.J. Macfarlane, S. Siebert, K. Gaffney.
Friday 14 June, How to treat SpA: Choices and outcomes with BDMARDS session 10.15-11.45 in Hall 7, 11.30 Abstract Number OP0233
 

POSTERS:

Frequency and reasons for switching back to biologic originator following initial switch to biologic biosimilar
R. Davies, L. Kearsley-Fleet, M. Lunt, K. Watson, BSRBR-RA Contributors Group, K.L. Hyrich on behalf of the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA)
Saturday 15 June, Poster Session, Number SAT0141


PUBLISHED WORK:

Early experience with JAK inhibitor prescribing in the UK: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA)
J. Page, L. Kearsley-Fleet, R. Davies, K. Watson, M. Lunt, K.L. Hyrich and the BSRBR-RA


Thank you and congratulations to all authors and contributors for developing these papers and disseminating the latest findings to the rheumatology community. 
 

If you're attending the EULAR congress, be sure to head to the EULAR Village Stand V08 to say hello to the British Society for Rheumatology team who will be raising awareness of #BSR20 Annual Conference, the Rheumatology and RAP Journals, Membership and the rest of the society's work. 


More detail of the EULAR programme is available here.